AB RELATIVE VALUE FUND, INC.
Fund
CABDX
Price as of:
$6.04
+ $0.02
+ 0.33%
Primary Theme
fund company
Name
As of 09/27/2023Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
3.1%
1 yr return
24.5%
3 Yr Avg Return
20.7%
5 Yr Avg Return
11.3%
Net Assets
$1.88 B
Holdings in Top 10
36.8%
52 WEEK LOW AND HIGH
$6.0
N/A
N/A
Expenses
OPERATING FEES
Expense Ratio 0.94%
SALES FEES
Front Load 4.25%
Deferred Load N/A
TRADING FEES
Turnover 55.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$2,500
IRA
$2,500
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 09/27/2023Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
CABDX - Profile
Distributions
- YTD Total Return 3.1%
- 3 Yr Annualized Total Return 20.7%
- 5 Yr Annualized Total Return 11.3%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio 0.79%
- Dividend Yield 1.2%
- Dividend Distribution Frequency Annual
Fund Details
-
Legal NameAB RELATIVE VALUE FUND, INC.
-
Fund Family NameALLIANCEBE
-
Inception DateJun 29, 1998
-
Shares OutstandingN/A
-
Share ClassA
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerFrank Caruso
Fund Description
The Fund invests primarily in the equity securities of U.S. companies that the Adviser believes are trading at attractive valuations that have strong or improving business models. The Adviser monitors the fundamental performance of the Fund’s investments for signs of future financial success. The Adviser relies heavily upon the fundamental analysis and research of its dedicated investment team for the Fund in conducting research and making investment decisions. The team initially screens a primary research universe of largely U.S. companies for attractive security valuation and business model characteristics. Once appropriate candidates have been identified for further analysis, the team conducts fundamental research to better understand the company’s business model. In evaluating a company for potential inclusion in the Fund, the Adviser takes into account many factors that it believes bear on the company’s ability to perform in the future, including attractive free cash flow valuations, high levels of profitability, stable‑to‑improving balance sheets, and management teams that are good stewards of shareholder capital.
The Adviser recognizes that the perception of “value” is relative and often defined by the future economic performance of the company. As a result of how individual companies are valued in the market, the Fund may be attracted to investments in companies with different market capitalizations (i.e., large-, mid‑ or small-capitalization) or companies engaged in particular types of businesses, although the Fund does not intend to concentrate in any particular sectors or industries. At any period in time, the Fund’s portfolio emphasis upon particular industries or sectors will be a by‑product of the stock selection process rather than the result of assigned targets or ranges.
The Fund may enter into derivatives transactions, such as options, futures contracts, forwards, and swaps. The Fund may use options strategies involving the purchase and/or writing of various combinations of call and/or put options, including on individual securities and stock indices, futures contracts (including futures contracts on individual securities and stock indices) or shares of exchange-traded funds (“ETFs”). These transactions may be used, for example, in an effort to earn extra income, to adjust exposure to individual securities or markets, or to protect all or a portion of the Fund’s portfolio from a decline in value, sometimes within certain ranges.
CABDX - Performance
Return Ranking - Trailing
| Period | CABDX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 3.1% | -13.0% | 45.3% | 31.09% |
| 1 Yr | 24.5% | -62.7% | 51.5% | 17.91% |
| 3 Yr | 20.7%* | -24.5% | 62.7% | 21.97% |
| 5 Yr | 11.3%* | -16.1% | 28.5% | 23.32% |
| 10 Yr | 11.3%* | -17.0% | 13.5% | 14.18% |
* Annualized
Return Ranking - Calendar
| Period | CABDX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2022 | -11.2% | -65.1% | 4.6% | 43.16% |
| 2021 | 15.4% | -44.2% | 57.5% | 54.31% |
| 2020 | 1.6% | -23.2% | 285.0% | 30.93% |
| 2019 | 17.8% | -21.4% | 48.5% | 60.72% |
| 2018 | -18.0% | -38.8% | 16.7% | 63.89% |
Total Return Ranking - Trailing
| Period | CABDX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 3.1% | -12.1% | 45.3% | 31.09% |
| 1 Yr | 24.5% | -16.6% | 45.5% | 17.91% |
| 3 Yr | 20.7%* | -12.9% | 76.6% | 21.97% |
| 5 Yr | 11.3%* | -8.1% | 41.7% | 23.32% |
| 10 Yr | 11.3%* | 1.3% | 24.8% | 14.18% |
* Annualized
Total Return Ranking - Calendar
| Period | CABDX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2022 | 2.8% | -42.0% | 8.5% | 23.85% |
| 2021 | 39.4% | -38.6% | 129.7% | 23.59% |
| 2020 | 2.8% | -22.6% | 304.8% | 59.69% |
| 2019 | 28.4% | -0.1% | 52.1% | 35.84% |
| 2018 | -5.8% | -28.4% | 17.5% | 20.28% |
NAV & Total Return History
CABDX - Holdings
Concentration Analysis
| CABDX | Category Low | Category High | CABDX % Rank | |
|---|---|---|---|---|
| Net Assets | 1.88 B | 404 K | 87.6 B | 33.97% |
| Number of Holdings | 69 | 2 | 1727 | 60.38% |
| Net Assets in Top 10 | 692 M | 405 K | 32.3 B | 29.07% |
| Weighting of Top 10 | 36.79% | 5.0% | 99.2% | 17.47% |
Top 10 Holdings
- AB Fixed Income Shares, Inc. - Government Money Market Portfolio 5.13%
- Elevance Health Inc 4.17%
- Berkshire Hathaway Inc 3.92%
- JPMorgan Chase Co 3.89%
- Philip Morris International Inc 3.81%
- Alphabet Inc 3.55%
- Mastercard Inc 3.31%
- Roche Holding AG 3.29%
- Gilead Sciences Inc 3.02%
- Regeneron Pharmaceuticals Inc 2.70%
Asset Allocation
| Weighting | Return Low | Return High | CABDX % Rank | |
|---|---|---|---|---|
| Stocks | 94.66% | 28.02% | 125.26% | 84.22% |
| Cash | 6.22% | -88.20% | 71.98% | 7.97% |
| Preferred Stocks | 0.00% | 0.00% | 12.57% | 21.26% |
| Other | 0.00% | -2.02% | 26.80% | 37.96% |
| Convertible Bonds | 0.00% | 0.00% | 3.66% | 15.82% |
| Bonds | 0.00% | 0.00% | 80.18% | 17.52% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | CABDX % Rank | |
|---|---|---|---|---|
| Industrials | 19.36% | 0.00% | 42.76% | 3.26% |
| Healthcare | 18.00% | 0.00% | 30.08% | 46.49% |
| Financial Services | 16.97% | 0.00% | 58.05% | 72.91% |
| Consumer Cyclical | 9.60% | 0.00% | 22.74% | 12.21% |
| Consumer Defense | 9.30% | 0.00% | 34.10% | 37.12% |
| Technology | 9.19% | 0.00% | 54.02% | 65.38% |
| Energy | 5.25% | 0.00% | 54.00% | 78.85% |
| Communication Services | 4.87% | 0.00% | 26.58% | 61.45% |
| Real Estate | 4.18% | 0.00% | 90.54% | 33.36% |
| Basic Materials | 2.29% | 0.00% | 21.69% | 73.66% |
| Utilities | 0.99% | 0.00% | 27.04% | 84.36% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | CABDX % Rank | |
|---|---|---|---|---|
| US | 94.66% | 24.51% | 121.23% | 68.52% |
| Non US | 0.00% | 0.00% | 37.91% | 42.69% |
CABDX - Expenses
Operational Fees
| CABDX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 0.94% | 0.04% | 45.41% | 49.54% |
| Management Fee | 0.55% | 0.00% | 1.50% | 44.02% |
| 12b-1 Fee | 0.25% | 0.00% | 1.00% | 27.53% |
| Administrative Fee | N/A | 0.01% | 0.50% | N/A |
Sales Fees
| CABDX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | 4.25% | 0.00% | 5.75% | 89.88% |
| Deferred Load | N/A | 0.95% | 5.00% | N/A |
Trading Fees
| CABDX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| CABDX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 55.00% | 0.00% | 488.00% | 69.48% |
CABDX - Distributions
Dividend Yield Analysis
| CABDX | Category Low | Category High | CABDX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 1.25% | 0.00% | 42.57% | 49.05% |
Dividend Distribution Analysis
| CABDX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Annual | Annually | Quarterly | Annually |
Net Income Ratio Analysis
| CABDX | Category Low | Category High | CABDX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | 0.79% | -1.51% | 4.28% | 78.28% |
Capital Gain Distribution Analysis
| CABDX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually | Annually | Annually | Annually |
Distributions History
| Date | Amount | Type |
|---|---|---|
| Dec 15, 2020 | $0.068 | OrdinaryDividend |
| Dec 17, 2019 | $0.250 | OrdinaryDividend |
| Dec 18, 2018 | $0.067 | OrdinaryDividend |
| Dec 20, 2017 | $0.050 | OrdinaryDividend |
| Dec 21, 2016 | $0.101 | OrdinaryDividend |
| Dec 23, 2015 | $0.055 | OrdinaryDividend |
| Dec 24, 2014 | $0.044 | OrdinaryDividend |
| Dec 23, 2013 | $0.044 | OrdinaryDividend |
| Dec 24, 2012 | $0.033 | OrdinaryDividend |
| Dec 20, 2011 | $0.042 | OrdinaryDividend |
| Dec 27, 2010 | $0.026 | OrdinaryDividend |
| Dec 28, 2009 | $0.035 | OrdinaryDividend |
| Dec 26, 2008 | $0.049 | OrdinaryDividend |
| Dec 19, 2006 | $0.050 | OrdinaryDividend |
| Mar 29, 2005 | $0.010 | OrdinaryDividend |
| Dec 27, 2004 | $0.010 | OrdinaryDividend |
| Sep 28, 2004 | $0.010 | OrdinaryDividend |
| Jun 29, 2004 | $0.010 | OrdinaryDividend |
| Mar 30, 2004 | $0.010 | OrdinaryDividend |
| Dec 26, 2003 | $0.010 | OrdinaryDividend |
| Sep 26, 2003 | $0.010 | OrdinaryDividend |
| Jun 27, 2003 | $0.010 | OrdinaryDividend |
| Mar 28, 2003 | $0.010 | OrdinaryDividend |
| Dec 27, 2002 | $0.010 | OrdinaryDividend |
| Sep 25, 2002 | $0.010 | OrdinaryDividend |
| Jun 19, 2002 | $0.010 | OrdinaryDividend |
| Mar 20, 2002 | $0.010 | OrdinaryDividend |
| Dec 19, 2001 | $0.010 | OrdinaryDividend |
| Sep 26, 2001 | $0.010 | OrdinaryDividend |
| Jun 20, 2001 | $0.010 | OrdinaryDividend |
| Mar 20, 2001 | $0.010 | OrdinaryDividend |
| Dec 20, 2000 | $0.010 | OrdinaryDividend |
| Sep 20, 2000 | $0.010 | OrdinaryDividend |
| Jun 20, 2000 | $0.010 | OrdinaryDividend |
| Mar 20, 2000 | $0.010 | OrdinaryDividend |
| Dec 20, 1999 | $0.010 | OrdinaryDividend |
| Sep 20, 1999 | $0.010 | OrdinaryDividend |
| Jun 18, 1999 | $0.010 | OrdinaryDividend |
| Mar 18, 1999 | $0.010 | OrdinaryDividend |
| Dec 23, 1998 | $0.010 | OrdinaryDividend |
| Sep 18, 1998 | $0.010 | OrdinaryDividend |
| Jun 19, 1998 | $0.010 | OrdinaryDividend |
| Mar 18, 1998 | $0.010 | OrdinaryDividend |
| Dec 23, 1997 | $0.013 | OrdinaryDividend |
| Sep 19, 1997 | $0.013 | OrdinaryDividend |
| Jun 17, 1997 | $0.013 | OrdinaryDividend |
| Mar 17, 1997 | $0.125 | OrdinaryDividend |
| Dec 13, 1996 | $0.013 | OrdinaryDividend |
| Sep 19, 1996 | $0.013 | OrdinaryDividend |
| Jun 18, 1996 | $0.013 | OrdinaryDividend |
| Mar 19, 1996 | $0.013 | OrdinaryDividend |
| Dec 20, 1995 | $0.096 | OrdinaryDividend |
| Sep 29, 1995 | $0.013 | OrdinaryDividend |
| Jun 30, 1995 | $0.013 | OrdinaryDividend |
| Mar 30, 1995 | $0.013 | OrdinaryDividend |
| Sep 30, 1994 | $0.013 | OrdinaryDividend |
| Jun 30, 1994 | $0.013 | OrdinaryDividend |
| Mar 30, 1994 | $0.015 | OrdinaryDividend |
| Sep 01, 1993 | $0.015 | OrdinaryDividend |
| Jun 30, 1993 | $0.015 | OrdinaryDividend |
| Mar 31, 1993 | $0.015 | OrdinaryDividend |
| Dec 30, 1992 | $0.015 | OrdinaryDividend |
| Sep 30, 1992 | $0.015 | OrdinaryDividend |
| Jun 30, 1992 | $0.015 | OrdinaryDividend |
| Mar 31, 1992 | $0.015 | OrdinaryDividend |
| Dec 30, 1991 | $0.015 | OrdinaryDividend |
| Sep 30, 1991 | $0.015 | OrdinaryDividend |
| Jun 28, 1991 | $0.020 | OrdinaryDividend |
| Mar 28, 1991 | $0.020 | OrdinaryDividend |
| Dec 31, 1990 | $0.037 | OrdinaryDividend |
| Sep 27, 1990 | $0.020 | OrdinaryDividend |
| Jun 26, 1990 | $0.020 | OrdinaryDividend |
| Mar 28, 1990 | $0.020 | OrdinaryDividend |
CABDX - Fund Manager Analysis
Managers
Frank Caruso
Start Date
Tenure
Tenure Rank
Dec 31, 2004
17.42
17.4%
Frank Caruso is a Senior Vice President and Chief Investment Officer of US Growth Equities since 2012. He joined the firm in 1993, when it acquired Shields Asset Management, where he had been director of Equities. Previously, he was a managing director and senior member of the Investment Policy Committee at Shearson Lehman Advisors.He holds a BA in business economics from the State University of New York, Oneonta, and is a member of the New York Society of Security Analysts and the CFA Institute. He is a CFA charterholder. Location: New York
Vinay Thapar
Start Date
Tenure
Tenure Rank
Apr 11, 2018
4.14
4.1%
Vinay Thapar is a Senior Vice President and Co-Chief Investment Officer for US Growth Equities and a Portfolio Manager for the Global Healthcare Strategy. He is also a Senior Research Analyst, responsible for covering global healthcare. Before joining the firm in 2011, Thapar spent three years at American Century Investments as a senior investment analyst responsible for healthcare. Prior to that, he worked for eight years at Bear Stearns in the Biotech Equity Research Group, most recently as an associate director. Thapar holds a BA in biology from New York University and is a CFA charterholder. Location: New York
John Fogarty
Start Date
Tenure
Tenure Rank
Apr 11, 2018
4.14
4.1%
John H. Fogarty is a Senior Vice President and Co-Chief Investment Officer for US Growth Equities. He rejoined the firm in 2006 as a fundamental research analyst covering consumer-discretionary stocks in the US, having previously spent nearly three years as a hedge fund manager at Dialectic Capital Management and Vardon Partners. Fogarty began his career at AB in 1988, performing quantitative research, and joined the US Large Cap Growth team as a generalist and quantitative analyst in 1995. He became a portfolio manager in 1997. Fogarty holds a BA in history from Columbia University and is a CFA charterholder. Location: New York
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.09 | 86.59 | 7.96 | 16.42 |